INTRODUCTION
A central belief in neurobiology is that neurons are not mitotic cells. Despite this, prior to full differentiation and maturation, there is evidence that neurons are not qualitatively different from mitotic cells. As with mitotic cells, cell-division has been shown in differentiating neurons in knockout (KO) and conditional KO models of negative cellcycle regulators (Aijoka et al., 2007; Chen et al., 2004; Ferguson et al., 2002; Oshikawa et al., 2013; Xu et al., 2014; Zindy et al., 1999) , in immature neurons (Anda et al., 2016; Ray et al., 1993; Oshikawa et al., 2017) , and in mature neurons after undergoing dedifferentiation (Friedmann-Morvinski et al., 2012) . In contrast, in mature neurons that are normally differentiated, acute induction of cell-cycle re-entry results in cell-death instead 3 of cell-division (Al-Ubaidi et al., 1992; Anda et al., 2016; Feddersen et al., 1992; Kuan et al., 2004; Verdaguer et al., 2002) , reflecting that the mitotic limitations of neurons are gradually attained with maturation (Anda et al., 2016) . Thus, we are yet to explain why any form of mitotic activity can take place in postmitotic neurons. Further, mitotic activity in neurons may evidence that the "postmitotic cell" concept is inaccurate altogether.
Along these lines, adult mammalian cardiomyocytes have also been traditionally considered irreversibly postmitotic yet recent evidence shows they can undergo celldivision (Bersell et al., 2009 ). Hence, we are yet to prove whether postmitotic cells such as neurons are not mitotic cells after all.
If mature neurons are mitotic cells, they should have a functional cell-cycle machinery that can result in neuronal cell-division. Howbeit, determining whether neurons have functional cell-cycle machinery is challenging because there are no known physiological mitogens capable of inducing neuronal cell-cycle re-entry. Alternatively, non-physiological neuronal cell-cycle re-entry is reported in neurons (Frade and OvejeroBenito, 2015; Herrup and Yang, 2007; Yang et al., 2001 ). However, in mitotic cells, nonphysiological cell-cycle re-entry activates checkpoints that arrest the cell-cycle (Halazonetis et al., 2008; Manic et al., 2015; Musacchio and Salmon, 2007) and result in cell-death to prevent potentially cancerous cell division (Halazonetis et al., 2008; Vitale et al., 2011) . Thus, aberrant cell-cycle re-entry itself could cause oncosuppressive celldeath and prevent cell-division even if neurons are fully functional mitotic cells. This oncosuppressive signaling can be overcome by abrogating cell-cycle checkpoints in S, G2 and M-phases (Halazonetis et al., 2008; Lan and Cleveland, 2010; Manic et al., 2015) .
Hence, if mature neurons are mitotic cells, checkpoint abrogation should afford celldivision even after non-physiological cell-cycle re-entry. 4 Cyclin E is the canonical late G1 cyclin that triggers transition into S-phase by activating Cyclin-dependent kinase 2 (Cdk2) (Teixeira and Reed, 2017) and is necessary for cell-cycle re-entry from quiescence (Geng et al., 2003) . Despite it is a proto-oncogene, Cyclin E is expressed in the brain to levels comparable to organs with proliferating cells (Odajima et al., 2011) , and Cyclin E upregulation is reported during aberrant neuronal cell-cycle re-entry (Copani et al., 1999; Verdaguer et al., 2002; Staropoli et al., 2003; Schwartz et al., 2007; Harbison et al., 2011; Absalon et al., 2013; Veas-Pérez de Tudela et al., 2015; Lee et al., 2017) and in AD (Hoozemans et al., 2002; Nagy et al., 1997) . In mitotic cells, oncogenic Cyclin E induces specific alterations of the cell-cycle machinery (Teixeira and Reed, 2017) . This enables the prediction of which cell-cycle checkpoints are likely to be activated in S, G2 and M-phases of mitotic cells. Thus, Cyclin E overexpression in neurons can be used to predict cell-cycle checkpoint activation and devise checkpoint abrogation strategies to determine the extent to which the cell-cycle is functional in neurons, namely whether neurons are mitotic cells.
We induced neuronal cell-cycle re-entry with an oncogenic low molecular weight (LMW) Cyclin E isoform (Cyclin ET1) (Porter et al., 2001) fused to Cdk2 (t1EK2). This was coupled with checkpoint signaling abrogation in S, G2 and M-phases to enable cellcycle progression. We also assessed whether neurons maintain the integrity of the axon initial segment (AIS), responsible for action potentials generation, after exiting the cellcycle without undergoing cell-division. We show that the regulation of S, G2 and M phases is as in standard mitotic cells and that after suppressing checkpoints neurons can divide. Moreover, neurons adapt their AIS to the cell-cycle.
RESULTS

t1EK2 induces DNA synthesis and apoptosis in differentiated neurons
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Endogenously expressed Cyclin E has been shown to be able to bind and activate Cdk2 (Schmetsdorf et al., 2009 ). However, under physiological conditions, Cyclin E forms catalytically inactive complexes with Cdk5 to promote synapse maturation (Odajima et al., 2011) . Cdk5 is necessary to prevent cell-cycle re-entry (Cicero and Herrup, 2005 ) and its deregulation is associated to neuron diseases (Su and Tsai, 2011) . Thus, to avoid possible interference of Cyclin E with Cdk5 signaling, we generated a t1EK2 fusion product to induce neuronal cell-cycle re-entry. t1EK2 or control LacZ were co-expressed with red fluorescent protein (RFP) to identify transfected neurons (identified by MAP2-specific labeling). We studied cell-cycle re-entry by assessing DNA replication with 5-bromo-2´-deoxyuridine (BrdU) incorporation. This analysis was performed 1, 1.5, 2, and 3 days after transfecting the oncogene in hippocampal neurons maintained for 15 days in vitro (DIV), a stage in which synapses have already been developed (Chin et al., 1995) .
Transfected control neurons never replicated DNA (n=491) ( Figure S1 ), confirming that neurons in primary culture at these stages of maturation do not spontaneously re-enter the cell-cycle. This is consistent with the gradual loss of mitotic capabilities of neurons with maturation (Anda et al., 2016) . In contrast, t1EK2 induced DNA synthesis in neurons (Figure 1a, b) . At 1 day post-transfection (dpt) 52.3 ± 4% t1EK2-expressing neurons incorporated BrdU (Figure 1a ). This increased at 1.5 dpt to 58.9 ± 4.3% and then declined to 46.8 ± 5.1% at 2 dpt. Neuronal cell-cycle re-entry induced by t1EK2 evidences that, at least downstream of Cyclin E/Cdk2 activation, the regulation of G1/S transition in neurons is shared with mitotic cells. We did not assess BrdU incorporation at 3 dpt due to widespread deterioration of t1EK2-expressing neurons, which was suggestive of neuronal death. This was not surprising, as Cyclin E is consistently associated to apoptosis during aberrant cell-cycle re-entry in neurons (Absalon et al., 2013; Copani et al., 1999; Lee et al., 2017; Schwartz et al., 2007; Veas-6 Pérez de Tudela et al., 2015; Verdaguer et al., 2002) . Thus, we assessed if t1EK2 was inducing apoptosis by active caspase-3 immunolabeling. The proportion of neurons expressing t1EK2 that were positive for active caspase-3 (34.7 ± 3.9 %) was already significantly higher than control neurons (6.0 ± 1.9 %) at 1.5 dpt (p < 0.001, Fisher's exact test) ( Figure 1c ). As expected, apoptotic neurons displayed pyknotic nuclei (Fig.   1d ). Hence, t1EK2 induced DNA synthesis was associated to apoptotic cell-death in neurons. experiments for a (X 2 test of independence and Bonferroni corrected post hoc tests, 1 dpt: n=153, 1.5 dpt: n=129. and 2 dpt: n=94). Three independent experiments for c (Fisher's exact test, ***p<0.001, LacZ-expressing Control; n=150, t1EK2: n=150). Scale bar: 12.5 µm.
p53 tumor suppressor dysfunction rescues the neuronal cell-cycle
Apoptotic cell-death in neurons may be a consequence of checkpoint activation. Thus, we analyzed whether the neuronal cell-cycle could be rescued from apoptosis suppressing checkpoint signaling. Oncogenes, and deregulated Cyclin E in particular (Bartkova et al., 2006; Bester et al., 2011; Jones et al., 2013; Neelsen et al., 2013) , commonly generate DNA damage that can result in cell death by triggering the DNA damage response (DDR), which is part of the oncosuppressive response of mitotic cells to oncogene-induced cellcycle re-entry (Halazonetis et al., 2008) . Thus, rather than reflecting a postmitotic specific mechanism that elicits cell-death in response to any form of cell-cycle activity, neurons may be responding to t1EK2 by activating standard mitotic oncosuppressive mechanisms.
Cancerous cells can escape DDR-elicited apoptotic cell-death by inactivating mutations in tumor suppressor p53 (Halazonetis et al., 2008) . Along these lines, p53 loss of function synergizes with oncogenic Cyclin E in carcinogenic processes (Akli et al., 2007; BagheriYarmand et al., 2010; Bartkova et al., 2005; Minella et al., 2002; Smith et al., 2006) .
Thus, if the regulation of the cell-cycle of neurons is comparable to mitotic cells, a loss of function of p53 should rescue neuronal cell-cycle progression.
To contrast if this was the case, we induced loss of function of p53 by expressing a dominant negative mutant (p53DN) and again assessed apoptosis with active caspase-3. The proportion of active caspase-3 positive t1EK2/p53DN-expressing neurons (6.0 ± 1.9 %) was not statistically significantly different from control neurons expressing 8 p53DN (1.3 ± 0.9 %) at 1.5 dpt (p = 0.061, Fisher's exact test) (Figure 2a ). Hence, as in mitotic cells, p53 dysfunction prevented cell-cycle re-entry related cell-death. Moreover, rescued neurons occasionally showed mitotic chromatin condensation ( Figure 2b ; Movie 1) and could even be rarely be found undergoing possible attempts at cell-division ( Figure   S2a ).
To confirm that preventing cell death also rescued neurons with t1EK2-induced DNA replication, we quantified BrdU incorporation at 1, 2, and 3 dpt. Control neurons never replicated DNA (n=1,045) ( Figure S2b ). In contrast, inducing p53 loss of function in t1EK2-expressing neurons resulted in sustained BrdU labelling at 1 (38.8 ± 2.5 %), 2 (61.2 ± 2.8 %) and 3 dpt (61.8 ± 3.4 %) (Figure 2c, d) . Moreover, neurons with replicated DNA could still be found at 5 dpt ( Figure S2c ). Thus, in a process that is reminiscent of carcinogenesis in mitotic cells, our results suggest that p53 tumor suppressor loss of function synergizes with t1EK2 to rescue the neuronal cell-cycle. expressing Control; n=150, t1EK2/p53DN: n=150). Three independent experiments for c (X 2 test of independence and Bonferroni corrected post hoc tests, ***p<0.001, 1 dpt: n=376, 2 dpt: n=294. and 3 dpt: n=204). Scale bar: 12.5 µm.
Wee1 inhibition enables G2/M transition in differentiated neurons.
After rescuing the t1EK2-induced cell-cycle from apoptosis by abrogating p53 function, we wanted to determine whether neurons could continue cell-cycle progression beyond S-phase. To assess this possibility, we performed Phospho-Ser10 Histone H3 (pH3)
immunostaining to identify neurons in late G2 and M-phase (Hendzel et al., 1997) .
Consistent with the absence of spontaneous DNA replication, control MAP2-positive neurons were never positive for pH3 (n=150). In contrast, 45.3 ± 4.1% of RFP and MAP2-positive t1EK2/p53DN-expressing neurons reached late G2 (evidenced by pH3-specific foci) (Figure 3a ; Figure S3d ). Moreover, in fit with active caspase-3-negative neurons occasionally entering M-phase ( Figure 2b ; Movie 1, Figure S2a ), 2.7 ± 1.3% of t1EK2/p53DN-expressing neurons progressed beyond G2 into M-phase (characterized by pan-nuclear pH3 labelling) (Figure 3a ; see Figure S3a , b for protocol details). Therefore, although in most cases M-phase entry was blocked, neurons did progress into M-phase.
In mitotic cells, and especially in p53-deficient cells, DNA damage acquired during a genotoxic S-phase can result in G2 checkpoint activation, which blocks M-phase entry (Manic et al., 2015) . Cyclin E deregulation results in DNA damage by aberrantly activating the DNA replication machinery (Bartkova et al., 2006; Bester et al., 2011; Jones et al., 2013; Neelsen et al., 2013) . Thus, we assessed by Phospho-Ser139 Histone H2AX (γ-H2AX) immunostaining whether the presence of DNA damage in neurons supported a canonical block on M-phase. The proportion of neurons presenting more than 5 γ-H2AX foci was significantly higher in the t1EK2/p53DN-expressing group (78 ± 3.4 %) than in the p53DN-expressing controls (24 ± 3.5 %) at 1.5 dpt ( In mitotic cells, the M-phase block exerted by G2 checkpoint signaling is reversible (Manic et al., 2015) . This checkpoint largely relies on Cdk1 inhibitory phosphorylation effected by the Wee1 kinase. Thus, if neurons have standard regulation of G2/M transition, Wee1 inhibition should abrogate G2 checkpoint signaling and afford neuronal M-phase entry. To test this possibility, we abrogated the G2 checkpoint with the Wee1 kinase inhibitor MK1775 (Hirai et al., 2009 ) and again assessed M-phase entry.
Once in M-phase, the loss of pH3 staining begins at anaphase (Hendzel et al., 1997) .
Hence, we additionally blocked anaphase onset to capture all neurons that entered Mphase (see Figure S3a , c for protocol details). Control MAP2-positive neurons were not 11 found in late G2 or M-phase (n=150). In contrast, 31.3 ± 3.8 % of t1EK2-expressing neurons with p53 dysfunction entered M-phase ( Figure 3d ). Interestingly, 37.3 ± 3.9 % of neurons were still found in late G2 (Figure 3d ). Given the total percentage of neurons positive for pH3 staining was lower without Wee1 inhibition ( Figure 3a ) than with Wee1 inhibition (Figure 3d ), the latter was likely facilitating the progression of remaining neurons in early G2 and S-phase into late G2, in addition to enabling G2/M transition of those already at late G2. In support, the total percentage of neurons in late G2 and M- We observed that neurons in M-phase presented altered dendritic morphology (Movie 3). To gain insights into these alterations, we performed time-lapse experiments.
We expressed Histone H2B tagged with EGFP (H2B-GFP) to follow DNA dynamics and the RFP reporter protein to study morphological alterations. In interphase, neurons expressing t1EK2/p53DN generally remained apparently healthy with unaltered gross morphology (Movie 4, left). In contrast, M-phase entry usually involved a loss of RFP reporter signal from dendrites (Movie 4, right), which can reflect a process associated to mitotic cell-rounding. 
Differentiated neurons undergo cytokinesis
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In the previous experiments we prevented anaphase onset, and thus cell-division, to capture all neurons entering M-phase. Thus, to determine if neurons could undergo celldivision, we performed new time-lapse experiments without preventing anaphase.
However, we could not detect t1EK2/p53DN-expressing neurons clearly attempting celldivision. This could reflect limitations of the neuronal cell-cycle machinery or the effects of t1EK2/p53DN expression itself. The t1EK2 construct used in our experiments is based on a LMW Cyclin E isoform (Porter et al., 2001) . These isoforms are reported to induce anaphase/chromatin bridges (Bagheri-Yarmand et al., 2010) , which are formed by stretches of DNA that connect chromosomes during anaphase and can prevent celldivision (Fragkos and Naim, 2017). Chromatin bridges can result from unresolved aberrant DNA structures acquired during a deregulated S-phase and lead to cytokinesis failure.
To counter the possible negative effects of a deregulated S-phase on cell-division, we expressed topoisomerase-2α (TOP2α) to help in the resolution of chromatid intertwines that can underlie some of the aberrant DNA structures in chromatin bridges (Chen et al., 2015) ( Figure S4a ). Further, to attain a more robust inhibition of G2 checkpoint signaling, we used caffeine to inhibit G2 checkpoint signaling (Sarkaria et al., 1999) upstream of Wee1 (Manic et al., 2015 ) (see Figure S4a for protocol details).
Although still sparse and highly asynchronous, attempts at anaphase/cytokinesis could be detected in 12.9 % (n=93) of recorded neurons. Neurons largely underwent anaphase/cytokinesis failure (n=10) (Movie 5). Despite this, some neurons were able to complete cell-division (n=4), with daughter neurons having independent fates. One of the daughter neurons could die (Figure 4a ; Movie 6), or they could both remain viable ( Figure   4b ; Movie 7). We found that neurons could remain connected by intercellular bridges for hours prior to abscission (Figure 4a ; see Figure S4b for protocol details; Movie 6), 14 reflecting the presence of persistent chromatin bridges. Alternatively, cytokinesis could also proceed swiftly (Figure 4b ; see Figure S4c for protocol details; Movie 7). Therefore, despite oncogenic deregulation of the cell-cycle, neurons can complete cell-division.
Having ascertained that neurons can complete cell-division, we next assessed markers of telophase and cytokinesis machinery. As seen in time-lapse experiments, neurons did not undergo cell-division synchronously (Figure 4a , b; Movies 6, 7), which challenges its detection by immunocytochemistry. To overcome this limitation, we synchronized anaphase and cytokinesis onset by abrogating the Spindle Assembly Checkpoint (SAC). The SAC delays anaphase onset until the attachment between the kinetochores and the kinetochores fibers of the mitotic spindle are correct (Musacchio and Salmon, 2007) . Sustained SAC activation until proper attachment requires the Monopolar spindle 1 (Mps1) kinase (Lan and Cleveland, 2010) . Hence, we used the Mps1 inhibitor AZ3146 (Hewitt et al., 2010) to abrogate the SAC and induce synchronous onset of anaphase and cytokinesis (see Figure S4d , e for protocol details).
We assessed if neurons were assembling the cytokinesis machinery by anillin immunostaining. Anillin localizes at the cleavage furrow and remains in the midbody after ingression (Piekny and Maddox, 2010) . We found that, as stained by anillin, cleavage furrow ingression began (Fig. 4c ) and proceeded asymmetrically (Figure 4d) until the formation of the intercellular bridge/midbody (Figure 4e ; Movie 8). To the best of our knowledge, this is the first molecular evidence of the activation of the cytokinesis machinery in neurons. We were also able to detect putative daughter neurons ( Figure   S4f ). Next, we analyzed telophase by pH3 immunolabelling. The loss of pH3 staining begins at anaphase and is completed at telophase (Hendzel et al., 1997) . As expected, neurons undergoing cell-division displayed chromatin decondensation that was not 15 stained by pH3, whilst condensed chromatin in intercellular bridges retained pH3 labelling ( Figure 4f ; Movie 9).
The above results reflect that differentiated mature neurons can undergo celldivision. Axon initial segment integrity is coordinated with the cell-cycle 16 We have confirmed that neurons can reach telophase and assemble the cytokinesis machinery. Thus, neurons have a functional cell-cycle machinery. However, this does not ensure that the neuronal cell-cycle can be a viable program. In order to decipher whether the cell-cycle itself is not a fatal event in neurons; we analyzed changes in the AIS during cell-cycle progression. The AIS sustains neuronal polarity and integrates synaptic input to generate action potentials (Rasband, 2010) . Previous studies have demonstrated that AIS integrity is essential to maintain neuronal viability and function (Schafer et al., 2009; Del Puerto et al., 2015) . Within the AIS, AnkyrinG (AnkG) is the main protein and is necessary to maintain AIS functions, as a scaffold for voltage gated ion channels, and neuronal integrity (Rasband, 2010) . Thus, we analyzed AnkG expression by immunostaining across different phases within the cell-cycle and after cell-cycle exit (Fig.   5a ). However, we did not assess cell-cycle exit after cell-division because daughter neurons displayed signs of aneuploidy (see added mitotic mechanism to sustain a quiescent-like state which is nevertheless reversible.
Cell-cycle limitations in mitotic neurons.
We have induced cell-cycle re-entry with t1EK2, a fusion protein based on a LMW Cyclin E isoform and Cdk2. Cyclin E/Cdk2 is the holoenzyme that regulates canonical G1/S signaling in mitotic cells (Teixeira and Reed, 2017) . Thus, t1EK2 induced cell-cycle reentry evidences that canonical G1/S signaling is present in neurons. However, control neurons never undergo spontaneous cell-cycle re-entry. This also evidences the presence of non-canonical G0/G1 regulation in neurons. We suggest neurons possess standard G0/G1 signaling, including canonical negative cell-cycle regulators, with added noncanonical "mitotic suppressors" that prohibit physiological cell-cycle re-entry ( Figure   S5a ). As a result, physiological neuronal cell-division is prohibited. We also show neurons possess canonical S/G2/M cell-cycle checkpoints. If only pathological-like reentry is possible, checkpoints in S, G2 or M will be invariantly activated and block cellcycle progression and cell-division ( Figure S5b ). Hence, although neurons are mitotic cells, we suggest non-physiological proliferation is blocked by canonical cell-cycle checkpoints in S, G2 and M-phases whilst physiological proliferation is blocked by noncanonical "mitotic suppressors" in G0/G1.
Gathering the above, the quiescent-like state of mitotic neurons would depend on non-canonical machinery that prevents physiological cell-cycle re-entry. In mitotic cells, p21 CIP1 and p27 KIP are the canonical inhibitors of the catalytic activity Cyclin E/Cdk2 (Teixeira and Reed, 2018) . However, in neurons, Cdk5 sequesters Cyclin E into inactive Cyclin E/Cdk5 complexes (Odajima et al., 2011) . Cdk5 could therefore prevent Cyclin E/Cdk2 activity regardless of the downregulation of p21 CIP1 and p27 KIP stability during 20 attempts at physiological neuronal cell-cycle re-entry. Thus, we propose Cdk5 is a noncanonical "mitotic suppressor". In support, Cdk5 has been shown to be necessary to suppress the neuronal cell-cycle (Cicero and Herrup, 2005).
As we have shown, neuronal cell-division in differentiated mature neurons at postsynaptogenesis stages of development is possible. Further, AIS dynamics during the cell-cycle imply that a structural determinant of neuronal viability (Schafer et al., 2009) is coordinated with the cell-cycle. Hence, although we have not determined whether the AIS is recovered after neuronal cell-division, AIS recovery after premature cell-cycle exit suggests the neuronal cell-cycle is a highly coordinated viable program as in any mitotic cell. In extension, if we can induce physiological-like activation of the neuronal cell-cycle program, neuronal cell-division should be achieved without requiring the abrogation of cell-cycle checkpoints. One possible avenue to achieve physiological-like neuronal cellcycle re-entry and cell-division is by controlled abrogation of "mitotic suppressors"
( Figure S5c ). Future work will have to determine whether this can afford neuroregeneration. For now, we have established that it is no longer impossible.
Mitotic pathology in neurons
Cell-death is one way to prevent the proliferation of potentially cancerous cells (Halazonetis et al., 2008; Vitale et al., 2011) . In pathologies such as AD, Parkinson's disease, amyotrophic lateral sclerosis or brain injury, cell-cycle re-entry is associated to heightened susceptibility to cell-death instead of cell-division (Frade and Ovejero-Benito, 2015; Herrup and Yang, 2007; Yang et al., 2001) . This observation has led to the suggestion that the cell cycle machinery becomes pro-apoptotic as neurons acquire a mature postmitotic phenotype (Chatterjee et al., 2016; Greene et al. 2007; Konishi et al., 2002) . Nevertheless, we have proven that the mitotic machinery itself is not proapoptotic 21 in mature neurons. Therefore, cell-death in response to cell-cycle deregulation in neuron diseases may not be part of the disease itself but, to the contrary, necessary to prevent cancer ( Figure S5b ). Senescence also prevents cancerous proliferation by stripping mitotic cells from their proliferative capacity (Halazonetis et al., 2008; Coppé et al., 2010; Vitale et al., 2011) . Unlike cell-death, senescence entails exiting the cell-cycle into a state that can be viable. Senescence could explain why neurons that re-enter the cell-cycle in AD can remain viable for years as hyperploid cells (Arendt et al., 2010; Herrup and Yang, 2007; López-Sánchez et al., 2017) . Indeed, we evidence multinucleated neurons can remain viable and recover the AIS after cell-cycle exit without cell-division, and multinucleated neurons have been previously reported in AD patients (Zhu et al., 2008) .
Future work will have to determine whether there is a pathophysiological role for senescence in neuron disease (Fielder et al., 2017) . This will require the study of viable neuronal cell-cycle re-entry. To the best of our knowledge, our model with multinucleated neurons is the first of this type.
METHODS
Plasmids
Construction of a vector encoding a truncated form of Cyclin E (Trunk 1), which lacks the first 39 amino acids of Cyclin E (Porter et al., 2001) , fused to Cdk2 isoform 1 (NCBI accession number NP_001789) (t1EK2) was based on the EK2 fusion protein described previously (Jahn et al., 2013) . Briefly, a synthetic DNA construct encoding for t1EK2 was firstly cloned into the pUC vector, then subcloned into the HindIII and XbaI sites of (University of Sheffield, UK), has been previously described (Das et al., 2006) . The T7-p53DD-pcDNA3 vector expressing a dominant negative form of p53 (Irwin et al., 2000) was a gift from William Kaelin (Addgene plasmid # 25989). The H2B-GFP vector expressing a Histone-GFP fusion protein (Kanda et al., 1998 ) was a gift from Geoff Wahl (Addgene plasmid #11680). The TOP2α-WT pcDNA3.1(+) vector expressing topoisomerase IIα (Wu et al., 2016 ) was a kind gift from Corrado Santocanale (National University of Ireland).
Antibodies and inhibitory compounds
Primary purchased from Axon Medchem. The Eg5 inhibitor monastrol (ab14087), used at 100 µM, and the proteasome inhibitor MG132 (ab141003), used at 10µM, were purchased from Abcam. Caffeine (Sigma), used at 3 mM, was diluted in Neurobasal without LGlutamine (ThermoFisher Scientific) and filter sterilized with 0.2 μm syringe filters (Acrodisc).
Hippocampal Cultures
10-mm diameter coverslips (Menzel Glässer) were placed in 65% nitric acid (Merck) overnight. Coverslips were then washed 4 times in Milli-Q water (Millipore), once in pure ethanol (Merck) and air-dried. Coverslips were sterilized overnight in oven at 185ºC, placed in CELLSTAR cell culture dishes with 4 inner rings (Greiner bio-one) and UV sterilized for 1 h. Coverslips were coated with 0.5 mg/ml polyornithine (PLO) (SigmaAldrich) (prepared in 150 mM borate buffer, pH8.4) for at least 24 h. PLO was washed twice in sterilized Milli-Q water. CELLSTAR culture dishes were left in a humidified atmosphere containing 5 % CO2 at 37°C with 2ml of neuronal plating medium consistent of Dulbecco's modified Eagle medium (DMEM) with D-Glucose, L-Glutamine and Pyruvate (ThermoFisher Scientific) containing 10 % fetal bovine serum (FBS) (Life technologies) and penicillin-streptomycin (25 U/ml) (Gibco). Primary hippocampal neurons derived from CD-1 mice (Charles River) were harvested from embryonic day 17, staged as previously described (Kaufman, 1992) . Pups were decapitated and brains were placed in cold Hanks' balanced salt solution (HBSS) without calcium chloride, magnesium chloride, nor magnesium sulphate (Gibco). Hippocampi were then dissected and incubated for 15 min at 37ºC in 5 ml HBSS containing 2.5 mg/ml trypsin (Gibco) in 24 a 15 ml conical centrifuge tube. 1 mg/ml DNAse (Roche) was added for the last 30 s.
Hippocampi were then washed 5 times in 5 ml of HBSS at 37ºC each time. Mechanical dissociation followed in 1ml of HBSS at 37ºC by passing hippocampi through a Pasteur pipette 10-15 times. Non-dissociated tissue was allowed to collect at the bottom by gravity and clean supernatant with dissociated cells transferred to a new 15 ml centrifuge tube. 1 ml of HBSS at 37ºC was added to the remaining tissue and dissociated again with a flame polished Pasteur pipette to reduce the diameter of the tip 10-15 times. Nondissociated tissue was allowed to collect at the bottom by gravity. Clean supernatant with dissociated cells was transferred to the same centrifuge tube in which cells from the first dissociation were collected. Neurons were transferred at a density of 24.000 cells/cm 2 to CELLSTAR cell culture dishes (Greiner bio-one) with neuronal plating medium. Neurons were allowed to attach to coverslips for 3 to 4 h in a humidified atmosphere containing 5 % CO2 at 37°C. Once neurons were settled onto the coverslips, neuronal plating medium was washed with maintenance medium consistent of Neurobasal without L-Glutamine (ThermoFisher Scientific) medium supplemented with B27 (ThermoFisher Scientific), penicillin-streptomycin (25 U/ml) (Gibco) and GlutaMAX (Gibco) and differentiated with the same medium up to 3-4 DIV. Half of the culture medium was exchanged by fresh maintenance medium without penicillin-streptomycin every 3-4 days.
Lipofection
All lipofections were carried out in hippocampal neurons differentiated for 15 DIV. Two or three days prior to lipofection, half of the culture medium was changed for fresh growth medium without penicillin-streptomycin. In order to increase viability, recovery medium was prepared from conditioned medium of neuronal cultures and used after lipofection.
Thus, 30-60 min prior to lipofection, half of the conditioned medium of each neuronal 25 culture (1 ml) was removed and collected into a clean culture dish containing 1 ml of fresh growth medium. BrdU (5 µg/ml) and or inhibitors were added to the recovery medium as needed. The recovery medium was then incubated in a humidified atmosphere containing 5 % CO2 at 37°C for the duration of the lipofection. Neurobasal medium without supplements pre-warmed to 37°C was added to each of the neuronal cultures.
Cultures were returned to the incubator for a minimum of 30 min to stabilize CO2 levels.
To maximize viability, neurons were lipofected in their own culture dish and remaining conditioned medium, which was free of penicillin-streptomycin by 15 DIV. Neurons were 
Image analysis and cell counting studies
For BrdU incorporation time-course experiments, the proportion of BrdU positive neurons out of all MAP2 positive transfected neurons of 10-mm diameter coverslips (MenzelGlässer) was calculated in 3 independent experiments. To assess apoptosis, the proportion of active Caspase-3 (Mazumder et al., 2008) positive neurons of all MAP2
positive transfected neurons was calculated in each of 3 independent experiments. DNA damage was assessed with Phospho-Ser139 Histone H2AX (γ-H2AX) (Kinner et al., 2008) . The proportion of neurons with more than 5 γ-H2AX foci or γ-H2AX pan-nuclear staining out of all MAP2 positive transfected neurons was calculated in each of 3 independent experiments. Phospho-Ser10 Histone H3 (pH3) immunostaining was used to assess late G2 and M-phase entry (Hendzel et al., 1997) , wherein the proportion of neurons positive for foci (late G2) or pan-nuclear (M-phase) staining out of all MAP2 27 positive transfected neurons was calculated in each of 3 independent experiments in each treatment condition. Cell counting in BrdU, active Caspase-3, pH3 and γ-H2AX experiments was done with 20x (Zoom, 1.5) or 40x objectives with AF 6500-7000 fluorescence microscope (Leica) and a DU8285 VP-4324 camera (Andor). Confocal microscope images were acquired with 40x or 63x objectives using upright or inverted TCS SP5 confocal microscopes (Leica). For 3D image reconstructions, images were taken with a 63x objective with 1.7-to 3.6-times zoom, in 50 to 69 z-stacks of 0.13 to 0.25 µm step-sizes. 3D reconstructions and rotating 3D movies were generated using Icy bioimage informatics platform (de Chaumont et al., 2012) .
Live imaging of neuronal cell-cycle
Neurons were cultured as described above in µ-Dish 35mm, high Grid-500 cell culture dishes with ibidi polymer coverslip bottom (Ibidi) coated with 0.5 mg/ml polyornithine anaphase was identified by H2B-GFP (Kanda et al., 1998) and cleavage furrow ingression by RFP.
Measurement of the AIS
AnkyrinG (AnkG) was used to evaluate changes in the AIS of neurons at different stages of the cell-cycle. All groups were treated with Wee1 inhibitor MK1775 (Hirai et al., 2009) (900 nM) to abrogate the G2 checkpoint and with the Mps1 inhibitor AZ3146 (Hewitt et al., 2010 ) (10 µM) 2.5 h later to abrogate the SAC. Neurons in the interphase, prophase and prometaphase to telophase groups were fixed 3 h after G2 checkpoint abrogation.
Stages in between prometaphase and telophase could not be reliably distinguished by nuclear morphology and were thus grouped together. Multinucleated neurons were used to assess premature M-phase exit and were fixed 6 and 9 h after G2 checkpoint abrogation. Multinucleated neurons still presenting mitotic chromatin condensation or evidence of pyknosis were not included in the quantification. Neurons in all of the aforementioned groups co-expressed t1EK2/p53DN/TOP2α/RFP. Control neurons expressing LacZ/p53DN/TOP2α/RFP were fixed 9 h after G2 checkpoint abrogation.
Images were acquired on an upright Leica SP5 confocal microscope with a 63× objective, 1024 × 1024 pixels in z stacks with 0.5-μm steps and a Z-projection was obtained.
Measurements of AnkG fluorescence intensity were performed by Fiji-ImageJ software.
We drew a line starting at the limit of neuronal soma identified by MAP2 staining, and extended it along the AnkG staining or the RFP signal of the axon. Data were obtained after background subtraction. Then, data were smoothed every 1 μm using Sigma Plot 12.5 software. AIS start and end positions were obtained following the criteria described previously (Grubb and Burrone, 2010) . Then total fluorescence intensity for each AIS was obtained. Total fluorescent intensity was then divided by the length of the AIS to obtain the mean AnkG fluorescence per 1 µm (AnkG/µm). To avoid variability between 29 cell cultures and treatment exposure times, we normalized the mean AnkG/µm of transfected neurons to the nearest neighboring non-transfected neurons in the same image.
Statistical Analysis
Statistical analysis was performed using SPSS ( 
